These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34975523)

  • 41. Deep transcriptomic profiling of Dahl salt-sensitive rat kidneys with mutant form of Resp18.
    Ashraf UM; Mell B; Jose PA; Kumarasamy S
    Biochem Biophys Res Commun; 2021 Oct; 572():35-40. PubMed ID: 34340197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of diet and genetics on hypertension and renal disease in Dahl salt-sensitive rats.
    Mattson DL; Kunert MP; Kaldunski ML; Greene AS; Roman RJ; Jacob HJ; Cowley AW
    Physiol Genomics; 2004 Jan; 16(2):194-203. PubMed ID: 14600213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats.
    Roman RJ; Ma YH; Frohlich B; Markham B
    Hypertension; 1993 Jun; 21(6 Pt 2):985-8. PubMed ID: 8505111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP; Raij L
    Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease.
    Remuzzi A; Gagliardini E; Sangalli F; Bonomelli M; Piccinelli M; Benigni A; Remuzzi G
    Kidney Int; 2006 Apr; 69(7):1124-30. PubMed ID: 16395266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of proteinuria by angiotensin converting enzyme inhibition.
    Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
    Kidney Int; 1987 Jul; 32(1):78-83. PubMed ID: 3041097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
    Janssen JJ; Gans RO; van der Meulen J; Pijpers R; ter Wee PM
    Am J Hypertens; 1998 Sep; 11(9):1074-9. PubMed ID: 9752892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease.
    De Miguel C; Guo C; Lund H; Feng D; Mattson DL
    Am J Physiol Renal Physiol; 2011 Mar; 300(3):F734-42. PubMed ID: 21159736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salt-Sensitive Hypertension, Renal Injury, and Renal Vasodysfunction Associated With Dahl Salt-Sensitive Rats Are Abolished in Consomic SS.BN1 Rats.
    Potter JC; Whiles SA; Miles CB; Whiles JB; Mitchell MA; Biederman BE; Dawoud FM; Breuel KF; Williamson GA; Picken MM; Polichnowski AJ
    J Am Heart Assoc; 2021 Nov; 10(21):e020261. PubMed ID: 34689582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
    Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.
    Chen CC; Geurts AM; Jacob HJ; Fan F; Roman RJ
    Physiol Genomics; 2013 Feb; 45(3):110-8. PubMed ID: 23249995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria.
    Brown SA; Walton CL; Crawford P; Bakris GL
    Kidney Int; 1993 Jun; 43(6):1210-8. PubMed ID: 8391095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of immune factors in angiotensin II-induced hypertension and renal damage in Dahl salt-sensitive rats.
    Wade B; Petrova G; Mattson DL
    Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R323-R333. PubMed ID: 29118017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.
    Heeg JE; de Jong PE; van der Hem GK; de Zeeuw D
    Kidney Int; 1989 Aug; 36(2):272-9. PubMed ID: 2550696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats.
    O'Donnell MP; Kasiske BL; Katz SA; Schmitz PG; Keane WF
    Hypertension; 1992 Nov; 20(5):651-8. PubMed ID: 1428116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats.
    Remuzzi A; Benigni A; Malanchini B; Bruzzi I; Foglieni C; Remuzzi G
    Kidney Int; 1995 May; 47(5):1319-26. PubMed ID: 7637261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
    Otsuka F; Yamauchi T; Kataoka H; Mimura Y; Ogura T; Makino H
    Am J Physiol; 1998 Jun; 274(6):R1797-806. PubMed ID: 9841488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
    Remuzzi A; Imberti O; Puntorieri S; Malanchini B; Macconi D; Magrini L; Bertani T; Remuzzi G
    Am J Physiol; 1994 Dec; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Model of Oxalate Diet-Induced Chronic Kidney Disease in Dahl-Salt-Sensitive Rats.
    Dube P; Aradhyula V; Lad A; Khalaf FK; Breidenbach JD; Kashaboina E; Gorthi S; Varatharajan S; Stevens TW; Connolly JA; Soehnlen SM; Sood A; Marellapudi A; Ranabothu M; Kleinhenz AL; Domenig O; Dworkin LD; Malhotra D; Haller ST; Kennedy DJ
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.